SB2994 — GENETIC PRIVACY-NEUROTECH
Last action — Senate Committee Amendment No. 1 Rule 3-9(a) / Re-referred to Assignments
-
1Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill has been introduced in the Senate. Introduced January 29, 2026. It must pass committee before a floor vote.
Next likely step: a committee referral and hearing.
Odds of enactment
Low chanceBased on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.
Upgrade to see the exact probability and what's driving it.
A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.
Prognosis
Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.
Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.
In plain language
The bill limits the use of genetic and neurotechnology data by insurers and employers.
This bill amends the Genetic Information Privacy Act to include neurotechnology data, prohibiting its use by insurers for nontherapeutic purposes and by employers in employment decisions. It also establishes new privacy and security requirements for data collection.
What this means for you
- Workers: This means employers cannot consider neurotechnology data when making employment decisions.
- Healthcare: The bill requires stricter privacy and security measures regarding the handling of genetic and neurotechnology data.
Summary
Amends the Genetic Information Privacy Act. Adds legislative findings. Defines "neurotechnology" and "neurotechnology data". Prohibits insurers from using genetic testing or neurotechnology data (rather than only genetic testing) for nontherapeutic purposes or underwriting, with limited exceptions. Prohibits employers, employment agencies, labor organizations, and licensing agencies from requesting, requiring, or using neurotechnology data in employment decisions, subject to specified exceptions. Adds new provisions governing confidentiality, consent, privacy policies, and security requirements for entities collecting neurotechnology data. Regulates disclosure to government agencies and sets conditions for clinical research. Makes conforming changes. Effective January 1, 2027.
Bill Text
We don't have the full text on file for this bill yet.
Read SB2994 on the official Illinois source →Action History
-
Senate Committee Amendment No. 1 Rule 3-9(a) / Re-referred to Assignments
-
Rule 3-9(a) / Re-referred to Assignments
-
Rule 2-10 Committee/3rd Reading Deadline Established As May 22, 2026
-
Rule 2-10 Committee/3rd Reading Deadline Established As May 15, 2026
-
Rule 2-10 Committee Deadline Established As April 24, 2026
-
Rule 2-10 Committee Deadline Established As March 27, 2026
-
Senate Committee Amendment No. 1 To AI and Social Media
-
Senate Committee Amendment No. 1 Assignments Refers to Executive
-
Senate Committee Amendment No. 1 Referred to Assignments
-
Senate Committee Amendment No. 1 Filed with Secretary by Sen. Rachel Ventura
-
To AI and Social Media
-
Assigned to Executive
-
Referred to Assignments
-
First Reading
-
Filed with Secretary by Sen. Rachel Ventura
Sponsors
- Rachel Ventura · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 182 not signed on
Sponsors (1)
- Rachel Ventura Democrat
Co-sponsors (0)
None.
Not signed on (182)
182 members have not signed on to this bill.
Show all 182 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does SB2994 do?
- Amends the Genetic Information Privacy Act. Adds legislative findings. Defines "neurotechnology" and "neurotechnology data". Prohibits insurers from using genetic testing or neurotechnology data (rather than only genetic testing) for nontherapeutic purposes or underwriting, with limited exceptions. Prohibits employers, employment agencies, labor organizations, and licensing agencies from requesting, requiring, or using neurotechnology data in employment decisions, subject to specified exceptions. Adds new provisions governing confidentiality, consent, privacy policies, and security requirements for entities collecting neurotechnology data. Regulates disclosure to government agencies and sets conditions for clinical research. Makes conforming changes. Effective January 1, 2027.
- Who sponsors SB2994 ?
- SB2994 is sponsored by Rachel Ventura (Democrat).
- What is the current status of SB2994 ?
- This bill has been introduced in the Senate. Introduced January 29, 2026. It must pass committee before a floor vote.
- Where can I track SB2994 ?
- Track SB2994 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB2994
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB2994
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →